{"transactions":[{"id":3484304,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":156618,"kind":"person","name":"Tasker Sybil","position":1,"cik":"0001705900","reported_name":"Tasker Sybil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (option to buy)","published_at":"2019-06-19T16:01:29.000Z","date":"2019-06-17","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares will vest in 6 equal monthly installments, with the first vesting date on July 31, 2019."}],"balance_after":20000,"derivative":{"exercise_price":2.46,"expiration_date":"2024-06-17","underlying":"Common Stock, par value $0.0001","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-19-017407","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705900/000089924319017407/doc4.xml","form_type":"4"}},{"id":3576646,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":156618,"kind":"person","name":"Tasker Sybil","position":1,"cik":"0001705900","reported_name":"Tasker Sybil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (option to buy)","published_at":"2019-03-27T17:49:33.000Z","date":"2019-03-26","kind":"grant","acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares underlying the option become vested and exercisable on the first anniversary of the Grant Date and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following the one-year anniversary of the Grant Date, in each case, generally subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":38000,"derivative":{"exercise_price":2.95,"expiration_date":"2029-03-26","underlying":"Common Stock, par value $0.0001","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0000925421-19-000137","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705900/000092542119000137/edgar.xml","form_type":"4"}},{"id":3704297,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":156618,"kind":"person","name":"Tasker Sybil","position":1,"cik":"0001705900","reported_name":"Tasker Sybil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (option to buy)","published_at":"2019-01-04T16:59:18.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares underlying the option become vested and exercisable on the first anniversary of the Grant Date and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following the one-year anniversary of the Grant Date, in each case, generally subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":30000,"derivative":{"exercise_price":2.6,"expiration_date":"2029-01-02","underlying":"Common Stock, par value $0.0001","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001012975-19-000029","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705900/000101297519000029/edgar.xml","form_type":"4"}},{"id":3920718,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":156618,"kind":"person","name":"Tasker Sybil","position":1,"cik":"0001705900","reported_name":"Tasker Sybil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (option to buy)","published_at":"2018-05-23T17:26:49.000Z","date":"2018-05-21","kind":"grant","acquired":true,"shares":50016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the option becomes vested and exercisable on March 1, 2019, and the aggregate unvested remaining portion will vest and become exercisable in equal monthly installments on the first day of each month over the 36-month period starting April 1, 2019."}],"balance_after":50016,"derivative":{"exercise_price":0.445,"expiration_date":"2028-05-21","underlying":"Common Stock, par value $0.0001","underlying_shares":50016},"source":{"system":"sec-edgar","filing":"0001012975-18-000459","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705900/000101297518000459/edgar.xml","form_type":"4"}},{"id":4201633,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":156618,"kind":"person","name":"Tasker Sybil","position":1,"cik":"0001705900","reported_name":"Tasker Sybil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (option to buy)","published_at":"2017-09-26T18:37:48.000Z","date":"2017-09-22","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On the first anniversary of the date of grant, 25% of the unvested portion of the option will become vested and exercisable, and the aggregate remaining unvested portion will vest and become exercisable in equal monthly installments over the 36-month period following such anniversary date."}],"balance_after":50000,"derivative":{"exercise_price":2.48,"expiration_date":"2027-09-22","underlying":"Common Stock, par value $0.0001","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001012975-17-000722","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705900/000101297517000722/edgar.xml","form_type":"4"}},{"id":4288556,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":156618,"kind":"person","name":"Tasker Sybil","position":1,"cik":"0001705900","reported_name":"Tasker Sybil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (option to buy)","published_at":"2017-06-08T16:26:21.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in four equal annual installments commencing on the first anniversary of the date of grant."}],"balance_after":40000,"derivative":{"exercise_price":4.12,"expiration_date":"2027-06-06","underlying":"Common Stock, par value $0.0001","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001012975-17-000478","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705900/000101297517000478/edgar.xml","form_type":"4"}},{"id":4330258,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":156618,"kind":"person","name":"Tasker Sybil","position":1,"cik":"0001705900","reported_name":"Tasker Sybil","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options (option to buy)","published_at":"2017-05-08T20:37:45.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":48691,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Acquired pursuant to the Agreement and Plan of Merger, dated as of January 18, 2017 (as amended on March 29, 2017, the \"Merger Agreement\"), pursuant to which a wholly-owned subsidiary of the Issuer merged with and into Altimmune, Inc. (\"Altimmune\").  Pursuant to the Merger Agreement the Issuer assumed all outstanding options to purchase shares of Altimmune capital stock on a 0.749106:1 basis upon closing of the merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is currently exercisable to purchase 16,250 shares of the Issuer's common stock, par value $0.0001.  An additional 25% of the option will vest on each of 4/8/2018, 4/8/2019, and 4/8/2020."}],"balance_after":48691,"derivative":{"exercise_price":13.38,"expiration_date":"2026-04-07","underlying":"Common Stock, par value $0.0001","underlying_shares":48691},"source":{"system":"sec-edgar","filing":"0000899243-17-012364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705900/000089924317012364/doc4.xml","form_type":"4"}}]}